Product Evaluation for the Effectiveness of the ClearGuard® HD End Cap

Product Evaluation for the Effectiveness of the ClearGuard® HD End Cap

To assess blood stream infections in participants using two FDA-cleared devices: ClearGuard HD end caps compared to the Tego® connector with the CurosTM for Tego disinfecting port protector.

Prospective, cluster-randomized, open-label, post market, comparative effectiveness evaluation with facilities participating for up to 13 months.

Inclusion Criteria:

• All patients dialyzing with a central venous catheter

Exclusion Criteria:

• Known allergy to chlorhexidine